XML 68 R58.htm IDEA: XBRL DOCUMENT v3.24.2
FAIR VALUE MEASUREMENTS - Narrative (Details)
 3 Months Ended 6 Months Ended
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Contingent consideration $ 277,921,000   $ 277,921,000   $ 288,657,000
Business Combination, Contingent Consideration, Liability, Current 19,000,000   19,000,000    
Business Combination, Contingent Consideration, Liability, Noncurrent 258,900,000   258,900,000    
Venture capital investment fund          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Investment owned, at fair value 6,800,000   6,800,000   $ 5,200,000
Committed capital     18,000,000    
Committed capital callable $ 11,800,000   $ 11,800,000    
Product development and other milestone-based payments | Weighted average | Measurement Input, Probability of Success          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Contingent consideration liability, measurement input 0.90   0.90   0.89
Product development and other milestone-based payments | Weighted average | Measurement Input, Present-value Factor          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Contingent consideration liability, measurement input 0.061   0.061   0.058
Foreign exchange forward          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Derivative, notional amount $ 45,200,000   $ 45,200,000   $ 39,500,000
Derivative, fair value 0   0   0
Gain (Loss) on derivative instruments, net, pretax 0 $ 0 0 $ 0  
Thrive, Ashion and OmicEra | Fair value          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Contingent consideration $ 277,900,000   $ 277,900,000   $ 288,700,000